Vascular access

First Implantation of VasQ External Support Device in Greece

Retrieved on: 
Tuesday, January 23, 2024
Patient, Fistula, Gilon, International, Vascular access, Lamination, Chronic kidney disease, Physician

ATHENS, Greece, Jan. 23, 2024 /PRNewswire/ -- The first implantation of the VasQ™ external support device in Greece was successfully performed by Dr. Alexandros Mallios at Henry Dunant Hospital Center in Athens, Greece.

Key Points: 
  • ATHENS, Greece, Jan. 23, 2024 /PRNewswire/ -- The first implantation of the VasQ™ external support device in Greece was successfully performed by Dr. Alexandros Mallios at Henry Dunant Hospital Center in Athens, Greece.
  • As a visiting surgeon, Dr. Mallios worked with the center's physicians to introduce VasQ to patients served by the Henry Dunant Hospital Center.
  • The device is unique in that it is implanted around the artery-vein connection to provide permanent external support to the mobilized venous segment, which is the typical site of early fistula failure.
  • Laminate CEO Tammy Gilon expressed her enthusiasm for the successful inaugural VasQ case in Greece.

B. Braun Launches Introcan Safety® 2 IV Catheter with Multi-Access Blood Control Designed to Protect Clinicians Every Time the Hub is Accessed

Retrieved on: 
Wednesday, October 11, 2023
Workload, Risk, APG IV system, IV, Vascular access, Patient, Injury, Medical device, Chief security officer, Marketing

The Introcan Safety 2 IV Catheter is the latest development from B. Braun in a long line of passive needlestick prevention catheters.

Key Points: 
  • The Introcan Safety 2 IV Catheter is the latest development from B. Braun in a long line of passive needlestick prevention catheters.
  • In addition to automatic needlestick protection, clinicians are protected from blood exposure by a blood control feature every time the hub is accessed1 – reducing the risk of bloodborne pathogen exposure throughout the IV process.
  • In addition to needlestick injuries, mucocutaneous blood exposure due to blood spillage from the catheter hub is also a concern.
  • "The newly launched Introcan Safety 2 IV Catheter with Multi-Access Blood Control provides clinicians with another option when choosing the right device for their patients.

Dr. Charmaine Lok and Dr. Allen R. Nissenson Join PatenSee's Scientific Advisory Board

Retrieved on: 
Wednesday, September 20, 2023
Ottawa Hospital Research Institute, David Geffen School of Medicine at UCLA, National Kidney Foundation, Rockwell Medical, Kidney failure, University, Emeritus, Stenosis, Teaching, Physician, Renal replacement therapy, Coronavirus Scientific Advisory Board, Research, Mentorship, Associate, University Health Network, Dialysis, ASN, Patient, NKF, Nursing, DaVita Inc., Kidney, Renal Physicians Association, Reading, BPS Barbara Wilson Lifetime Achievement Award, ISCB Senior Scientist Award, Vascular access, UCLA, Therapy, Conference, Chronic kidney disease, Kidney disease, Award, Fistula, Medical device, Pharmaceutical industry, Medicine

OR YEHUDA, Israel, Sept. 20, 2023 /PRNewswire/ -- Dr. Charmaine Lok is the new Chairperson of the PatenSee Scientific Advisory Board. The company also announced today that Dr. Allen R. Nissenson has joined the company as a strategic advisor. PatenSee is developing a contactless imaging system to provide rapid vascular access monitoring for hemodialysis patients.

Key Points: 
  • OR YEHUDA, Israel, Sept. 20, 2023 /PRNewswire/ -- Dr. Charmaine Lok is the new Chairperson of the PatenSee Scientific Advisory Board.
  • The company also announced today that Dr. Allen R. Nissenson has joined the company as a strategic advisor.
  • I am delighted to join PatenSee as the chairperson of its Scientific Advisory Board and look forward to guiding this technology's further development to rapidly make it available for improving patient outcomes," said Dr. Lok.
  • Dr. Nissenson currently serves on the Board of Directors of Elicio Therapeutics, Rockwell Medical, Innocura Nephrology and Diality Inc.

The Inner Circle Acknowledges, J. Hudson Garrett, Jr. as a Pinnacle Life Professional for his contributions to the field of Health Care Administration and Policy

Retrieved on: 
Monday, September 11, 2023
Knowledge, American Hospital Association, Society, Infection, Neurocritical Care Society, Hope End, Inner circle, American College of Physicians, Health, Health administration, Journal, Theodore Levitt, Division, Practitioner, Pandemic, Nurse practitioner, Antimicrobial, American College, National Association, Hum Honorary Lifetime Achievement Award, University, Vascular access, Learning, Infectious Diseases Society of America, COVID-19, Georgia State University, Multimedia, Harvard Business Review, University of Louisville School of Medicine, Endemism, Public health, Control, Allied health professions, Society of Critical Care Medicine, Journal of the American Association of Nurse Practitioners, Above, Patient safety, Emergency medical services, Critical Care Medicine (journal), Nursing, Policy, Physician, Medicine

ATLANTA, Sept. 11, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, J. Hudson Garrett, Jr. is acknowledged as a Pinnacle Life Professional for his contributions to the field of Health Care Administration and Policy.

Key Points: 
  • ATLANTA, Sept. 11, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, J. Hudson Garrett, Jr. is acknowledged as a Pinnacle Life Professional for his contributions to the field of Health Care Administration and Policy.
  • Dr. Garrett Jr. pursued graduate education at Georgia State University where he earned a Ph.D. in Health Care Administration and Policy after earning a Master's degree in Business, Nursing, and Public Health.
  • With more than 22 years of experience in the field, Dr. Garrett Jr. established Community Health Associates in 2005 to bring healthcare professionals lifesaving emergency care and safety training.
  • The primary service the company offers is consulting to the healthcare industry, including providers, leaders, medical device companies, pharmaceutical companies, and others.

Teleflex Announces Extension of Arrow™ ErgoPack™ Complete System to Hemodialysis and Large Bore Central Venous Catheters

Retrieved on: 
Monday, August 21, 2023
Teleflex, Catheter, Workflow, CLABSI, CVC, TFX, CDC, OSHA, INS, Patient, Vascular access, NYSE, Medical device, Video game

This update is intended to streamline insertion workflow for clinicians and provide more options to suit their needs.

Key Points: 
  • This update is intended to streamline insertion workflow for clinicians and provide more options to suit their needs.
  • Clinicians can choose between Arrowg+ard Blue™ Hemodialysis or Large Bore lines in this expanded kit configuration, with a variety of French sizes, lumens, and lengths.
  • The Arrow™ ErgoPack™ Complete System expansion includes a variety of clinician-inspired updates:
    Option of 3M™ Tegaderm™ CHG I.V.
  • Advanced Securement Dressing with BioPatch® Protective Disk
    “Max barrier kits like the Arrow™ ErgoPack™ Complete System provide clinicians with the necessary components they need for their Acute Hemodialysis and Large Bore insertions.

ICU Medical Announces Second Quarter 2023 Results and Narrows Fiscal Year 2023 Guidance Ranges

Retrieved on: 
Monday, August 7, 2023
Sale, ICU Medical, Growth, Vascular access, ICU, EBITDA, Use, GAAP, ICUI, SAN, Bank statement

Second quarter 2023 revenue was $549.3 million, compared to $561.0 million in the same period last year.

Key Points: 
  • Second quarter 2023 revenue was $549.3 million, compared to $561.0 million in the same period last year.
  • GAAP gross profit for the second quarter of 2023 was $192.3 million, as compared to $167.6 million in the same period last year.
  • Adjusted diluted earnings per share for the second quarter of 2023 was $1.88 as compared to $1.37 for the second quarter of 2022.
  • Also, adjusted EBITDA was $98.1 million for the second quarter of 2023 as compared to $84.7 million for the second quarter of 2022.

Webinar on Addressing MARSI in Vascular Access: The Role of Skin Integrity in Infection Prevention, Presented by Covalon

Retrieved on: 
Wednesday, June 21, 2023
General Health, Oncology, Consumer, Medical Devices, Infectious Diseases, Hospitals, Children, Surgery, Baby, Maternity, Biotechnology, Medical Supplies, Health, Infection, Learning, IV, Health care, Tears, Scar, COV, Pain, Hospital, Patient, The Company, Vascular access, Role, Burns, Trauma, Skin, Medical imaging

​​​​​​​Whether it’s placing an IV-line, checking vitals, or administering life-saving treatment, patient care begins with the skin.

Key Points: 
  • ​​​​​​​Whether it’s placing an IV-line, checking vitals, or administering life-saving treatment, patient care begins with the skin.
  • Yet, medical adhesive related skin injury (MARSI) affects 1 in 5 vascular access patients, with rates of up to 55% in pediatric populations.
  • MARSI occurs when medical adhesives – peeled away from raw, vulnerable skin – cause the surface layers of the skin to be torn.
  • Takeaways from the webinar include:
    Title: Addressing MARSI in Vascular Access: The Role of Skin Integrity in Infection Prevention
    Choosing the right medical dressing for a patient can make the difference between pain vs comfort, infection vs healing, skin injury vs skin integrity.

Compassionate Care Solutions Provider Covalon Participating in the Canadian Vascular Access Association and World Congress on Vascular Access Joint Conference on April 26-28, 2023 in Toronto

Retrieved on: 
Wednesday, April 26, 2023
Learning, CVAA, Senior, CLABSI, Research, Sheraton Centre Toronto Hotel, Science, Patient, Vascular access, Fluid mechanics, FDA, Health, Global marketing, Conference, Pharmaceutical industry, Medical device

CVAA is the only Canadian national conference that brings together infusion therapy and vascular access professionals in Canada.

Key Points: 
  • CVAA is the only Canadian national conference that brings together infusion therapy and vascular access professionals in Canada.
  • WoCoVA aims to improve vascular access for patients worldwide by promoting the science and practice of vascular access.
  • Visit the Covalon booth to learn more about the company's vascular access and infection prevention solutions, and how Covalon is focused on compassionate care tech that benefits both patients and care providers.
  • IV Clear ® - the world's only dual-antimicrobial vascular access dressing that offers complete transparency at and around the insertion site for easy daily assessment.

B. Braun Launches Online e-University Platform for Healthcare Providers

Retrieved on: 
Tuesday, March 7, 2023
Transfer, Continuing education, Pain management, Health, Vascular access, Irrigation, Integrated access device, Ecosystem, Therapy, BSN, Education, RN, Patient, Pump, Asia e University, Nursing

BETHLEHEM, Pa., March 7, 2023 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, today unveiled B. Braun e-University , an online education platform for healthcare providers designed to improve clinical practice and patient care.

Key Points: 
  • BETHLEHEM, Pa., March 7, 2023 /PRNewswire/ -- B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, today unveiled B. Braun e-University , an online education platform for healthcare providers designed to improve clinical practice and patient care.
  • The learnings in B. Braun e-University help providers stay current with education, even during changeover and shortages in the education departments of some healthcare facilities.
  • In addition to B. Braun e-University, which focuses on hospital and outpatient markets, the Company has collaborated with the Association for Vascular Access to provide free online education on improving Peripheral Intravenous Catheter Insertion for healthcare schools ( AVA- B. Braun PIV Education ).
  • To browse and access this online education, visit B. Braun e-University .

Medline unveils new CLABSI prevention solution

Retrieved on: 
Thursday, January 27, 2022
Preventive healthcare, Centers for Disease Control and Prevention timeline, Health, DNP, Education, Maintenance, Center, CDC, Vascular access, CLABSI, Program, Infection, Solution, Pharmaceutical industry, Dentistry, Medicine, MEDLINE

NORTHFIELD, Ill., Jan. 27, 2022 /PRNewswire/ -- Medline announced today the launch of its Vascular Access Health Solution , a new central line-associated bloodstream infection (CLABSI) prevention solution driven by human factors-based strategies throughout the entire life of the line, from insertion to removal.

Key Points: 
  • NORTHFIELD, Ill., Jan. 27, 2022 /PRNewswire/ -- Medline announced today the launch of its Vascular Access Health Solution , a new central line-associated bloodstream infection (CLABSI) prevention solution driven by human factors-based strategies throughout the entire life of the line, from insertion to removal.
  • The CDC also reports the largest increase in CLABSI occurred in Q4 of 2020, at 47% across all location types.
  • In conjunction with the program, Medline formed a specialty vascular access salesforce to zero in on CLABSI reduction.
  • To learn more about Medline's Vascular Access Health Solution and clinically-driven infection prevention strategies, visit https://www.medline.com/infection-prevention/vascular-access-management .